Congress funds research into cancer disparities affecting Black women

What it does

This bill directs the National Institutes of Health to expand research into endometrial cancer and ensure African-American women are represented in clinical trials proportional to their disease incidence, while directing the CDC to develop and distribute public education materials about endometrial cancer risk factors and treatments. The bill authorizes $1 million annually for NIH research (2026–2028) and unspecified CDC funding for the same period, addressing documented disparities in diagnosis and mortality rates between African-American and white women.

Why we flagged it

The bill's operative mechanism is straightforward: expand NIH research capacity, mandate equitable clinical trial representation, and fund CDC public education. It is a health-equity measure addressing documented disparities in cancer diagnosis and outcomes.

What the text implies

• Mandating proportional representation of African-American women in endometrial cancer trials may require NIH to actively recruit and retain participants from underrepresented groups, potentially shifting trial design and recruitment practices across the institute.
• The bill's emphasis on disparities in diagnosis and mortality may indirectly incentivize development of screening tools or diagnostic protocols specifically validated in African-American populations, which could improve early detection.
• Coordination requirement across NIH institutes (Child Health, Minority Health, Women's Health) may create new inter-agency working groups or data-sharing protocols that persist beyond the bill's authorization period.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill addresses documented health disparities in endometrial cancer diagnosis and mortality, particularly for African-American women, by funding research and mandating equitable clinical trial representation. Public education materials and expanded research infrastructure benefit all women, especially those from underrepresented groups historically excluded from medical research.

Who stands to gain

• National Institutes of Health (research funding)
• Centers for Disease Control and Prevention (education program funding)
• Academic medical centers and research institutions (NIH grant recipients)
• Nonprofit organizations and media entities (CDC education material distribution partners)

Named in the bill

National Institutes of Health (NIH), Centers for Disease Control and Prevention (CDC), Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institute on Minority Health and Health Disparities, Office of Research on Women's Health, Health Resources and Services Administration (HRSA), Public Health Service Act

Where it stands

8 cosponsors: 8 Democrats.

• Sep 9, 2025 — Introduced · Congress.gov: “Introduced in House”
• Sep 9, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.